Keyword Analysis & Research: apixaban for dvt ppx
Keyword Research: People who searched apixaban for dvt ppx also searched
Search Results related to apixaban for dvt ppx on Search Engine
-
Apixaban (Eliquis) for the treatment of d…
https://www.kch.nhs.uk/wp-content/uploads/2023/01/pl-649.2-apixaban-eliquis-for-the-treatment-of-deep-vein-thrombosis-or-pulmonary-embolism.pdf
To treat deep vein thrombosis (DVT) or pulmonary embolism (PE), 10 mg apixaban should be taken twice a day for the first 7 days, followed by 5 mg twice a day for at least 3 months. For the prevention of recurrent disease, people who have completed 6 months of treatment for DVT or PE should take 2.5 mg twice a day.
DA: 96 PA: 19 MOZ Rank: 53
-
Apixaban for Extended Treatment of Venous Thromboembolism
https://www.nejm.org/doi/full/10.1056/NEJMoa1207541
WEBFeb 21, 2013 · Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism. Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John... Publish Year: 2013
Author: Giancarlo Agnelli, Harry R. Buller, Alexander Cohen, Madelyn Curto, Alexander S. Gallus, Margot John...
Publish Year: 2013
DA: 99 PA: 79 MOZ Rank: 88
-
Apixaban for the prophylaxis and treatment of deep vein …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556259/
WEBAug 26, 2015 · Apixaban is currently FDA-approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the prophylaxis of … Author: Molly W Mandernach, Rebecca J Beyth, Anita Rajasekhar Bioavailability: 50%, gastrointestinal Publish Year: 2015 Distribution: 87% protein bound
Author: Molly W Mandernach, Rebecca J Beyth, Anita Rajasekhar
Bioavailability: 50%, gastrointestinal
Publish Year: 2015
Distribution: 87% protein bound
DA: 10 PA: 16 MOZ Rank: 97
-
Dosing Guide - ELIQUIS
https://www.eliquis.com/eliquis/servlet/servlet.FileDownload?file=00P1Y000011vwqaUAA
WEBdosing for prophylaxis of dvt, which may lead to pe In patients already taking ELIQUIS ® (apixaban) at a dose of 2.5 mg twice daily: Avoid coadministration with combined P-gp …
DA: 92 PA: 49 MOZ Rank: 16
-
American Society of Hematology 2020 guidelines for …
https://ashpublications.org/bloodadvances/article/4/19/4693/463998/American-Society-of-Hematology-2020-guidelines-for
WEBOct 2, 2020 · The meta-analysis showed that, compared with a shorter course of anticoagulation, treating patients with a longer course of anticoagulation reduced the risk … Author: Thomas L. Ortel, Ignacio Neumann, Walter Ageno, Rebecca Beyth, Rebecca Beyth, Nathan P. Clark, Adam ... Publish Year: 2020
Author: Thomas L. Ortel, Ignacio Neumann, Walter Ageno, Rebecca Beyth, Rebecca Beyth, Nathan P. Clark, Adam ...
Publish Year: 2020
DA: 65 PA: 62 MOZ Rank: 2
-
Apixaban versus Enoxaparin for Thromboprophylaxis …
https://www.nejm.org/doi/full/10.1056/NEJMoa1110899
WEBDec 8, 2011 · Apixaban is an orally active direct inhibitor of activated factor X (factor Xa) with established efficacy and safety for the prevention of … Author: Samuel Z. Goldhaber, Alain Leizorovicz, Ajay K. Kakkar, Sylvia K. Haas, Geno Merli, Robert M. Knabb,... Publish Year: 2011
Author: Samuel Z. Goldhaber, Alain Leizorovicz, Ajay K. Kakkar, Sylvia K. Haas, Geno Merli, Robert M. Knabb,...
Publish Year: 2011
DA: 88 PA: 7 MOZ Rank: 39
-
Safety of apixaban for venous thromboembolism prophylaxis: the …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762581/
WEBFeb 18, 2016 · Apixaban (mg): 2.5 BID =9.9%, 5 QD =11.3%, 5 BID =4.8%, 10 QD =12.4%, 10 BID =5.5%, 20 QD =8.2%, enoxaparin =15.6%, warfarin =26.6% Apixaban: dose …
DA: 43 PA: 27 MOZ Rank: 95
-
American Society of Hematology 2021 guidelines for …
https://ashpublications.org/bloodadvances/article/5/4/927/475194/American-Society-of-Hematology-2021-guidelines-for
WEBFeb 11, 2021 · Recommendations 23, 24, and 25. For the short-term treatment of VTE (first 3-6 months) for patients with active cancer, the ASH guideline panel suggests DOAC (apixaban, edoxaban, or rivaroxaban) …
DA: 2 PA: 87 MOZ Rank: 96
-
Venous Thromboembolism Prophylaxis and Treatment in …
https://ascopubs.org/doi/10.1200/JCO.23.00294
WEBApr 19, 2023 · Apixaban was effective in reducing the risk of recurrent VTE, with a low risk of major bleeding. Recommendations. Apixaban and rivaroxaban were added as …
DA: 100 PA: 35 MOZ Rank: 30